Serial killing of tumor cells by cytotoxic T cells redirected with a CD19-/CD3-bispecific single-chain antibody construct
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference24 articles.
1. Bispecific antibodies in cancer therapy
2. The role of B7 co-stimulation in activation and differentiation ofCD4+and CD8+T cells
3. Tumor Escape from Immune Response: Mechanisms and Targets of Activity
4. HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story
5. Down-Regulation of HLA Class I Antigen-Processing Molecules in Malignant Melanoma
Cited by 287 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nephrotoxicity in Bispecific Antibodies Recipients: Focus on T-Cell-Engaging Bispecific Antibodies;OncoTargets and Therapy;2024-07
2. Bispecific and multispecific antibodies in oncology: opportunities and challenges;Nature Reviews Clinical Oncology;2024-05-31
3. Optimizing Clinical Translation of Bispecific T‐cell Engagers through Context Unification with a Quantitative Systems Pharmacology Model;Clinical Pharmacology & Therapeutics;2024-05-15
4. Bispecific T-cell engagers in childhood B-acute lymphoblastic leukemia;Haematologica;2024-05-10
5. Pretransplant Blinatumomab Improves Outcomes in B Cell Acute Lymphoblastic Leukemia Patients Who Undergo Allogeneic Hematopoietic Cell Transplantation;Transplantation and Cellular Therapy;2024-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3